Medication Adherence and Use of Inhaler Devices in Patients With Asthma or COPD
A Pharmacist-Led Intervention on Medication Adherence and Inhaler Usage on Clinical Outcomes Among Patients With Asthma and Chronic Obstructive Pulmonary Disease in Ibadan, Nigeria
1 other identifier
interventional
130
1 country
1
Brief Summary
This study aims to evaluate the impact of a pharmacist-led intervention programme on medication adherence and use of inhaler devices on clinical outcomes of patients with asthma and COPD attending a tertiary health facility in Nigeria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2024
CompletedFirst Submitted
Initial submission to the registry
May 13, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedMay 16, 2024
May 1, 2024
5 months
May 13, 2024
May 13, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Medication adherence
The difference between the intervention and control groups with respect to the changes in the medication adherence score from baseline to a 2-month follow-up.
Two months
Use of inhaler devices
The difference between the intervention and control groups with respect to the changes in knowledge of the use of inhaler devices from baseline to a 2-month follow-up.
Two months
Secondary Outcomes (1)
disease control
Two months
Study Arms (2)
Control
NO INTERVENTIONIntervention
EXPERIMENTALPatients in the intervention group received education and counselling tips about their disease condition and medications
Interventions
The pharmacist intervention was aimed at identifying and addressing barriers to treatment adherence through tailored strategies
Eligibility Criteria
You may qualify if:
- Patients 18 years of age and older with a primary diagnosis of asthma or COPD by a physician who are willing to complete the study and have telephone access
You may not qualify if:
- All non-consenting patients and patients who are not on any medications at any point in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University College Hospital
Ibadan, Oyo State, 200212, Nigeria
Related Publications (1)
Adisa R, Ufuah UF, Ige OM. Impact of pharmacist-led intervention in medication adherence and inhaler usage on asthma and chronic obstructive pulmonary disease control: a quasi-experimental study. BMC Health Serv Res. 2024 Oct 8;24(1):1199. doi: 10.1186/s12913-024-11683-9.
PMID: 39379970DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Graduate Student
Study Record Dates
First Submitted
May 13, 2024
First Posted
May 16, 2024
Study Start
October 4, 2023
Primary Completion
February 28, 2024
Study Completion
February 28, 2024
Last Updated
May 16, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share